SCHEDULE: PRIMECAP Boosts Xencor Stake to 14.79%

PRIMECAP Management Co. reports an increased passive stake of 14.79% in Xencor, Inc., holding over 10.5 million shares.

Summary

• PRIMECAP Management Co. beneficially owns 10,527,322 shares of Xencor, Inc. common stock.
• This ownership represents 14.79% of Xencor's total outstanding common stock.
• PRIMECAP holds sole voting power and sole dispositive power over all 10,527,322 shares.
• This filing is Amendment No. 17 to a Schedule 13G, indicating an update to a previously reported ownership position.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Xencor.
• PRIMECAP Odyssey Aggressive Growth Fund is noted as having an interest of more than five percent of Xencor, Inc.'s total outstanding common stock.

Sentiment

Score: 7

Explanation: The filing indicates a significant and continued passive investment by a reputable asset manager, PRIMECAP Management Co., in Xencor, Inc., suggesting ongoing confidence in the company's value.

Positives

• A major institutional investor, PRIMECAP Management Co., maintains a substantial 14.79% stake in Xencor, Inc., signaling continued confidence in the company.
• The holding is passive, indicating the investor is not seeking to influence control, which can be viewed positively by current management and stability.

Negatives

• None identified in this passive ownership filing.

Risks

• Potential for future divestment by a significant shareholder, which could impact the stock price.

Future Outlook

This filing does not provide forward-looking statements or guidance from Xencor, Inc. It solely reports a passive ownership stake by an investment adviser.

Industry Context

This filing reflects a significant passive investment by a major asset manager, PRIMECAP Management Co., in Xencor, Inc., a biotechnology company. Such large institutional holdings are common in the biotech sector, where long-term investment in promising drug development pipelines is typical.

Comparison to Industry Standards

• PRIMECAP Management Co.'s 14.79% stake in Xencor, Inc. is a substantial holding for an institutional investor, often indicating a high conviction in the company's long-term prospects.
• For comparison, other large institutional investors like Vanguard and BlackRock frequently hold similar or larger passive stakes (e.g., 5-15%) in publicly traded biotechnology companies, reflecting their broad market index or actively managed fund strategies.

Stakeholder Impact

• Shareholders: The continued significant stake by a major institutional investor may instill confidence and potentially stabilize the stock price.
• Management: The passive nature of the investment suggests no immediate pressure for strategic or operational changes from this shareholder.

Key Dates

Recommendation

The filing indicates a substantial and continued passive investment by PRIMECAP Management Co., a reputable institutional investor, in Xencor, Inc. This suggests a long-term positive view on the company's prospects. While the filing itself does not provide new operational or financial data, the sustained large institutional ownership is a supportive factor for existing shareholders, warranting a 'hold' recommendation.

Keywords

Xencor, PRIMECAP, institutional ownership, Schedule 13G, passive investment, biotechnology, common stock